Pseudomonas Infections

"Pseudomonas Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Infections with bacteria of the genus PSEUDOMONAS.

Descriptor ID	D011552
MeSH Number(s)	C01.252.400.739
Concept/Terms	Pseudomonas Infections Pseudomonas Infections Infections, Pseudomonas Infection, Pseudomonas Pseudomonas Infection Pseudomonas aeruginosa Infection Pseudomonas aeruginosa Infection Pseudomonas aeruginosa Infections

Below are MeSH descriptors whose meaning is more general than "Pseudomonas Infections".

Diseases [C]
Bacterial Infections and Mycoses [C01]
Bacterial Infections [C01.252]
Gram-Negative Bacterial Infections [C01.252.400]
Pseudomonas Infections [C01.252.400.739]

Below are MeSH descriptors whose meaning is related to "Pseudomonas Infections".

Below are MeSH descriptors whose meaning is more specific than "Pseudomonas Infections".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pseudomonas Infections" by people in this website by year, and whether "Pseudomonas Infections" was a major or minor topic of these publications.

Bar chart showing 60 publications over 23 distinct years, with a maximum of 6 publications in 2010 and 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	0	2
1997	0	1	1
2004	1	0	1
2005	1	0	1
2006	1	0	1
2007	0	1	1
2008	1	0	1
2009	2	2	4
2010	5	1	6
2011	3	0	3
2012	2	1	3
2013	3	0	3
2014	1	2	3
2015	0	1	1
2016	2	0	2
2017	4	2	6
2019	5	0	5
2020	4	0	4
2021	2	0	2
2023	4	0	4
2024	0	2	2
2025	2	1	3
2026	1	0	1

Below are the most recent publications written about "Pseudomonas Infections" by people in Profiles.

Fleck RC, Gorodyna O, Zhou H, Bryant H, Gadjeva M, Shea AE. Emerging pathogens in urinary tract infections: virulence and phenotypic characterization of Pseudomonas aeruginosa strains. mSphere. 2026 Jun 30; 11(6):e0015126.

View in: PubMed
Truong-Bolduc QC, Wang Y, Lawton BG, Zweifach JJ, McDevitt GM, El Abdellaoui Y, Brown Harding H, Yonker LM, Rahme LG, Vyas JM, Hooper DC. NorA and Tet38 efflux pumps enable Staphylococcus aureus survival in the cystic fibrosis airway environment, resistance to antibiotics, and coinfection with Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2025 08 06; 69(8):e0046025.

View in: PubMed
Yu X, Song Y, Dong T, Ouyang W, Quan C, Shao L, Barasa L, Thompson PR, Zhang M, Ma J, Kurabayashi K, Li Y. Citrullination of NF-?B p65 by PAD2 as a Novel Therapeutic Target for Modulating Macrophage Polarization in Acute Lung Injury. Adv Sci (Weinh). 2025 May; 12(18):e2413253.

View in: PubMed
Zhou H, Negr?n O, Abbondante S, Marshall M, Jones B, Ong E, Chumbler N, Tunkey C, Dixon G, Lin H, Plante O, Pearlman E, Gadjeva M. Spatial transcriptomics identifies novel Pseudomonas aeruginosa virulence factors. Cell Genom. 2025 Mar 12; 5(3):100805.

View in: PubMed
Tse-Kang SY, Wani KA, Peterson ND, Page A, Humphries F, Pukkila-Worley R. Intestinal immunity in C.?elegans is activated by pathogen effector-triggered aggregation of the guard protein TIR-1 on lysosome-related organelles. Immunity. 2024 10 08; 57(10):2280-2295.e6.

View in: PubMed
Dong T, Barasa L, Yu X, Ouyang W, Shao L, Quan C, Wang SH, Zhang J, Salmon M, Tsung A, Alam HB, Ma J, Thompson PR, Li Y. AFM41a: A Novel PAD2 Inhibitor for Sepsis Treatment-Efficacy and Mechanism. Int J Biol Sci. 2024; 20(13):5043-5055.

View in: PubMed
Gras E, Vu TTT, Nguyen NTQ, Tran VG, Mao Y, Tran ND, Mai NH, Dong OX, Jung DH, Iorio NLPP, Povoa HCC, Pinheiro MG, Aguiar-Alves F, Weiss WJ, Zheng B, Cheng LI, Stover CK, Sellman BR, DiGiandomenico A, Gibault L, Valour F, Diep BA. Development and validation of a rabbit model of Pseudomonas aeruginosa non-ventilated pneumonia for preclinical drug development. Front Cell Infect Microbiol. 2023; 13:1297281.

View in: PubMed
Kim JS, Montesi SB, Adegunsoye A, Humphries SM, Salisbury ML, Hariri LP, Kropski JA, Richeldi L, Wells AU, Walsh S, Jenkins RG, Rosas I, Noth I, Hunninghake GM, Martinez FJ, Podolanczuk AJ. Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis. Ann Am Thorac Soc. 2023 12; 20(12):1683-1693.

View in: PubMed
Ramadan A, Cao Z, Hassan M, Zetterberg F, Nilsson UJ, Gadjeva M, Rathinam V, Panjwani N. Galectin-8 Downmodulates TLR4 Activation and Impairs Bacterial Clearance in a Mouse Model of Pseudomonas aeruginosa Keratitis. J Immunol. 2023 02 15; 210(4):398-407.

View in: PubMed
Ramadan A, Cao Z, Gadjeva M, Zaidi TS, Rathinam VA, Panjwani N. The NLRP3 Inflammasome Is Required for Protection Against Pseudomonas Keratitis. Invest Ophthalmol Vis Sci. 2023 02 01; 64(2):11.

View in: PubMed

People

Explore

Similar Concepts

Top Journals